Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026

GOCO vs CRVL: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

CRVL Wins Head-to-Head Institutional Verdict (5–0 across 6 Pillars · 9–1 Matrix Metrics)

CRVL Overall Winner 6-Pillar Tally: GOCO 0 – 5 CRVL (1 Tie) Matrix Metrics: GOCO 1 – 9 CRVL

As of Nov 17, 2026, Corvel Corp (CRVL) is the stronger overall head-to-head candidate over GoHealth, Inc. (GOCO) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). GOCO carries a Unified Composite Score of 42.9/100 (HOLD) at $0.30 (N/M Forward P/E, -292.0% operating margin), whereas CRVL carries 36.6/100 (SELL) at $87.48 (23.8x Forward P/E, 15.9% operating margin).

  • Composite vs. Pillar Nuance: While GOCO currently prints a higher short-term Unified Composite Score (42.9/100 HOLD vs. CRVL 36.6/100 SELL), CRVL captures the overall institutional head-to-head verdict (9–1 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (15.9% vs. -292.0% operating margin) and revenue trajectory (+11.5% vs. -94.6% YoY).
  • Technical & Structure Timing Caution: GOCO is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 23.9); meanwhile CRVL trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 65.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About GOCO vs CRVL
GOCO NASDAQ
GoHealth, Inc. Class A Common Stock
Insurance Agents, Brokers & Service
$0.30
+5.14% 1D
Market Cap $8.5M
TTM Revenue $153M
Forward P/E N/M
Beta / 30D Vol 2.15β · 201% Vol
Unified Composite Score
42.9 / 100 HOLD
Tech 40.0 Fund 46.0 Flow 50.0 Mom 48.9
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -32.2%), weak momentum, RSI 24
RSI-14: 23.9 · SMA20: $0.59 · SMA50: $0.88
CRVL NASDAQ Head-to-Head Winner
Corvel Corp
Insurance Agents, Brokers & Service
$87.48
+0.17% 1D
Market Cap $4.3B
TTM Revenue $1.01B
Forward P/E 23.8x
Beta / 30D Vol -0.17β · 33% Vol
Unified Composite Score
36.6 / 100 SELL
Tech 25.0 Fund 34.0 Flow 50.0 Mom 25.9
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (8.8% over 20 days), RSI 66
RSI-14: 65.8 · SMA20: $84.05 · SMA50: $78.41

6-Pillar Scorecard Institutional Category Breakdown (GOCO 0 – 5 CRVL)

Columns: Metric · GOCO · CRVL
1. Valuation Multiples CRVL
Forward P/E N/M 23.8x
Trailing P/E N/M 36.0x
PEG Ratio N/M N/M
EV / Revenue 0.1x 4.3x
2. Growth & Scale CRVL
Revenue Growth (YoY) -94.6% +11.5%
Earnings Growth (YoY) +424.1% +24.1%
TTM Revenue (USD) $153M $1.01B
Market Cap $8.5M $4.3B
3. Profitability & Quality CRVL
Gross Margin 57.3% 25.5%
Operating Margin -292.0% 15.9%
Net Profit Margin -189.7% 12.0%
Return on Equity (ROE) -289.9% 30.6%
4. Balance Sheet & Cash Flow CRVL
Cash Generation (TTM) -$148M EBITDA $195M EBITDA
Cash Flow Margin -96.9% EBITDA Mgn 19.3% EBITDA Mgn
Net Cash / Leverage $0.13 Book/Sh · -289.9% ROE $8.54 Book/Sh · 30.6% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) 187.6% (100th %ile)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Markup
6. R&D & Supply-Chain Moat CRVL
OpEx & R&D Intensity N/A 9.6% of Rev ($97M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Scale & Operating Efficiency Moat
Supply-Chain Role Insurance Brokers Operator Insurance Brokers Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: GOCO (1) vs CRVL (9)
Institutional Metric GOCO CRVL Criterion Row Edge
Market Capitalization
Scale
$8.5M $4.3B Larger Scale CRVL
Trailing P/E Ratio
Valuation
N/M 36.0x Lower Multiple CRVL
Forward P/E Ratio
Valuation
N/M 23.8x Lower Multiple CRVL
Revenue Growth (YoY)
Growth
-94.6% +11.5% Higher Growth CRVL
Operating Margin (TTM)
Profitability
-292.0% 15.9% Higher Margin CRVL
Net Profit Margin
Profitability
-189.7% 12.0% Higher Margin CRVL
Return on Equity (ROE)
Capital Efficiency
-289.9% 30.6% Higher ROE CRVL
52-Week Range Position
Momentum
0% ($0–$7) 95% ($45–$90) Stronger Trend CRVL
Beta / 30D Volatility
Risk Regime
2.15β · 201% Vol -0.17β · 33% Vol Lower Realized Risk CRVL
Unified Institutional Score
Composite Signal
42.9 / 100 (HOLD) 36.6 / 100 (SELL) Higher Composite GOCO
Trailing 12M Revenue (USD)
Operating Scale
$153M $1.01B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
57.3% 25.5% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 0.1x EV/Rev N/M PEG · 4.3x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$148M EBITDA ($0.13 Book/Sh · -289.9% ROE) $195M EBITDA ($8.54 Book/Sh · 30.6% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon CRVL +67.13 pp
GOCO: -64.69% · CRVL: +2.44%
3M Horizon CRVL +91.12 pp
GOCO: -81.52% · CRVL: +9.6%
6M Horizon CRVL +73.95 pp
GOCO: -90.56% · CRVL: -16.61%
1Y Horizon CRVL +67.37 pp
GOCO: -87.97% · CRVL: -20.6%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on GOCO vs CRVL. Trailing 12-month operating profitability (GOCO -292.0% vs CRVL 15.9%) and valuation multiples (GOCO N/M vs CRVL 23.8x Forward P/E) are benchmarked directly in Pillar 4 below.

GOCO ADR TTM Benchmark FX-Normalized USD
TTM Revenue$153M
Gross Margin57.3%
Op. Margin-292.0%
ROE / Fwd P/E-289.9% · N/M
CRVL ADR TTM Benchmark FX-Normalized USD
TTM Revenue$1.01B
Gross Margin25.5%
Op. Margin15.9%
ROE / Fwd P/E30.6% · 23.8x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
GOCO UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact GOCO Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
CRVL UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 187.6%
IV Percentile 100th %ile
Put/Call OI Skew N/A
IV Regime Extreme (>80th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact CRVL Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
GOCO Moat Profile Cyclical / Execution-Driven Positioning
Insurance Brokers Operator
Competes within the Insurance Brokers value chain with $8.5M market capitalization and -292.0% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
CRVL Moat Profile Scale & Operating Efficiency Moat
Insurance Brokers Operator
Competes within the Insurance Brokers value chain with $4.3B market capitalization and 15.9% operating margin.
OpEx & R&D Reinvestment 9.6% of Rev ($97M)
90D Engineering Disclosures 0 Published

Investor FAQ GOCO vs CRVL Key Questions & Quantitative Answers

As of Nov 17, 2026, Corvel Corp (CRVL) is the stronger overall head-to-head candidate over GoHealth, Inc. (GOCO) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). GOCO carries a Unified Composite Score of 42.9/100 (HOLD) at $0.30 (N/M Forward P/E, -292.0% operating margin), whereas CRVL carries 36.6/100 (SELL) at $87.48 (23.8x Forward P/E, 15.9% operating margin). Composite vs. Pillar Nuance: While GOCO currently prints a higher short-term Unified Composite Score (42.9/100 HOLD vs. CRVL 36.6/100 SELL), CRVL captures the overall institutional head-to-head verdict (9–1 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (15.9% vs. -292.0% operating margin) and revenue trajectory (+11.5% vs. -94.6% YoY). Technical & Structure Timing Caution: GOCO is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 23.9); meanwhile CRVL trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 65.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

CRVL leads the Growth & Scale pillar: GOCO posts -94.6% YoY revenue growth and +424.1% YoY earnings growth on $153M TTM revenue (57.3% gross margin, -292.0% operating margin), compared with CRVL at +11.5% YoY revenue growth and +24.1% YoY earnings growth on $1.01B TTM revenue (25.5% gross margin, 15.9% operating margin). On trailing 12-month operating scale, GOCO generates $153M in USD-normalized revenue versus $1.01B for CRVL. In operating R&D and SG&A reinvestment, GOCO deploys N/A (0 90-day corporate R&D disclosures) versus 9.6% of Rev ($97M) (0 disclosures) for CRVL.

CRVL screens cheaper on headline valuation multiples. GOCO trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.1x EV/Revenue (-96.9% EBITDA margin), whereas CRVL trades at 23.8x Forward P/E, 36.0x Trailing P/E, N/M PEG, and 4.3x EV/Revenue (19.3% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against GOCO (-289.9% ROE) versus CRVL (30.6% ROE) capital efficiency.

In options market volatility and institutional positioning, GOCO carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (2.15β · 201% Vol realized risk). By comparison, CRVL carries 187.6% implied volatility (100th %ile, Extreme (>80th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.17β · 33% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.